Haohua Fu

Prof. Dr. Haohua Fu


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2024 in Foods
Verified
Journal Article
Open access
PDF file
CLChuxin Liu
Chuxin Liu
HEHe Enqi
He Enqi
PFPeitao Fu
Peitao Fu
LHLeli He
Leli He
LZLei Zhou
Lei Zhou
WQWei Quan
Wei Quan
In order to elucidate the development of quality properties in the fat portion of Chinese bacon during low-temperature smoking (LTS), raw pork was cured for five days, followed by infusion with smoked liquid and a subsequent ten-day smoking period characterized by alternating high and low-temperature conditions. The physicochemical characteristics and microstructures of the fat portion of the Chinese bacon were examined at three stages: the raw meat stage (Control), the curing stage (C3d and C5d), and the smoking stage (S5d and S10d). The results showed that LTS increased the hardness, transparency, and b* value of bacon fat. The increased contents of neutral lipids and free fatty acids, increased activities of neutral lipase and lipoxygenase, and increased peroxide and thiobarbituric acid reactive substance value indicated significant lipolysis and lipid oxidation of bacon fat during LTS. After the treatment, a decreased melting point and increased β′- and β-type fat crystal formation were observed in the fat portion. Moreover, the treatment led to disruption of the adipocyte membrane structure. Therefore, the destruction of adipocytes after lipolysis and lipid oxidation during low-temperature smoking treatment might contribute to the development of quality properties of bacon fat portions. Precise control of temperature and time enhances the stability of the fat portion of bacon, thereby improving quality characteristics such as texture and appearance.

30 July 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
HFHaohua Fu
Haohua Fu
NHNi Hengjia
Ni Hengjia
JWJianhui Wang
Jianhui Wang
TLTuo Leng
Tuo Leng
SWShusong Wu
Shusong Wu
YYYulong Yin
Yulong Yin
Gut lactic acid bacteria are emerging as potential targets for modulating host purine metabolism and alleviating hyperuricemia-related disorders. This study aimed to isolate purine-degrading lactic acid bacterial strains from porcine intestine and systematically evaluate their probiotic potential through both in vitro and in vivo approaches. A strain designated Pedio6-1 was isolated and identified as Pediococcus acidilactici based on 16S rRNA sequencing. In vitro assays demonstrated that P. acidilactici Pedio6-1 exhibited nearly complete adenine clearance (approaching 100%) and a total purine clearance rate of 30.73%, along with strong tolerance to acidic conditions, bile salts, and gastrointestinal enzymes. To further assess its in vivo efficacy, a high-fat diet-induced obese mouse model was employed. After 8 weeks of intervention, Pedio6-1 supplementation significantly reduced the final body weight and liver index, and markedly decreased hepatic guanine levels (p < 0.05), with a trend toward lower total purine content compared to the obese control group. Mechanistically, Pedio6-1 treatment significantly downregulated the hepatic mRNA expression of pro-inflammatory cytokines IL-1β and TLR4 (p < 0.05). Serum untargeted metabolomics revealed that Pedio6-1 treatment shifted the metabolic profile toward that of normal diet-fed mice, with differential pathways predominantly enriched in porphyrin metabolism and amino acid biosynthesis and metabolism. Notably, key metabolites with antioxidant and metabolic regulatory functions, including bilirubin, biliverdin, glutathione, citrate, L-cystathionine, and 4-pyridoxic acid, were significantly elevated following treatment, while N-acetylornithine and methylmalonate ester were decreased, indicating coordinated remodeling of oxidative stress defense, vitamin B6 homeostasis, and energy metabolism. Collectively, these findings indicate that Pedio6-1 not only possesses direct purine-degrading activity in vitro, but also ameliorates purine metabolic disturbances, inflammation, and oxidative stress in obese mice, likely through the modulation of porphyrin and amino acid metabolic pathways, highlighting its promise as a functional probiotic candidate for managing obesity-associated purine metabolic disorders.